Farewell EudraCT: all trial applications must now be submitted through EMA’s new portal
With the one-year grace period now over, sponsors need to use the Clinical Trials Information System for new clinical trial applications in the EU/EEA.

With the one-year grace period now over, sponsors need to use the Clinical Trials Information System for new clinical trial applications in the EU/EEA.
The trial will include healthy subjects aged 18 to 55 years who will be randomised in 4:1 ratio, with 15 subjects per cohort.
The global pharmaceutical industry experienced a 10% rise in new job postings related to social responsibility in Q3 2022 compared…
Tevogen Bio reports positive data from Covid-19 T cell therapy trial
Cyrano to initiate Phase II trial of nasal spray therapy for Hyposmia
Shionogi commences Phase I/II/III and Phase III trials of Covid-19 vaccine
Ascletis doses subjects in first cohort of Covid-19 oral therapy trial